EZH2 and gastric cancer: In a mouse model, the pro-inflammatory cytokine-driven downregulation of EZH2 maintains SASP by demethylating H3K27me3 marks and promotes peritoneal tumor formation in gastric cancer (GC) via JAK/STAT3 signaling [125].